Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma

Oral Oncology

Volumn 50, Issue 6, 2014, Pages 527-538

  Yip, Timothy T C ^a   Ngan, Roger K C ^a   Fong, Alvin H W ^a   Law, Stephen C K ^b  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b Hong Kong Adventist Hospital   (Hong Kong)

Author keywords

BamH1 W; Distant metastasis; EBER1; EBNA1; Epstein Barr virus; Head and Neck cancer; Local recurrence; Nasopharyngeal Cancer; Plasma EBV DNA; TaqMan quantitative real time PCR

Indexed keywords

CIRCULATING EPSTEIN BARR VIRUS DNA; UNCLASSIFIED DRUG; VIRUS DNA;

CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISTANT METASTASIS; EPSTEIN BARR VIRUS; HUMAN; NASOPHARYNX CARCINOMA; NONHUMAN; PLASMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SERUM; TREATMENT RESPONSE; VIRUS LOAD; BLOOD; GENETICS; IN SITU HYBRIDIZATION; METASTASIS; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR RECURRENCE; VIROLOGY;

DNA, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84900488822     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.12.011     Document Type: Review

References (85)

1. Hong Kong Cancer Registry. Top Ten Cancers in 2010. Hong Kong Hospital Authority; 2010. < http://www3.ha.org.hk/cancereg/statistics.html >.
2. Hong Kong Cancer Stat 2007, Hong Kong Cancer Registry, Hospital Authority; 2009.
3. G. Henle, W. Henle, and G. Klein Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells Int J Cancer 8 2 1971 272 282
4. H.C. Ho, M.H. Ng, H.C. Kwan, and J.C. Chau Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma Br J Cancer 34 6 1976 655 660
5. M.L. Hammarskjöld, S.C. Wang, and G. Klein High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector Gene 43 1-2 1986 41 50
6. V. Maréchal, M.C. Meyohas, I. Joab, S. Gaha, J.F. Giot, and A. Sergeant et al. Enzyme-linked immunosorbent assay for antibodies to ZEBRA, an Epstein-Barr trans-activator Res Virol 144 5 1993 397 404
7. P. Feng, S.H. Chan, M.Y. Soo, D. Liu, M. Guan, and E.C. Ren et al. Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis Cancer 92 7 2001 1872 1880
8. H.F. Chen, M. Sauter, P. Haiss, and N. Müller-Lantzsch Immunological characterization of the Epstein-Barr virus phosphoprotein PP58 and deoxyribonuclease expressed in the baculovirus expression system Int J Cancer 48 6 1991 879 888
9. K.C. Chow, J. Ma, L.S. Lin, K.H. Chi, S.H. Yen, and S.M. Liu et al. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D Cancer Epidemiol Biomarkers Prev 6 5 1997 363 368
10. Y. Connolly, E. Littler, N. Sun, X. Chen, P.C. Huang, and S.N. Stacey et al. Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma Int J Cancer 91 5 2001 692 697
11. Y. Chen, K. Yao, H. Sun, J. Qing, and G.Y. Peng Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies Chin Med J (Engl) 118 9 2005 725 730
12. Y.M. Lo, L.Y. Chan, K.W. Lo, S.F. Leung, J. Zhang, and A.T. Chan et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Cancer Res 59 6 1999 1188 1191
13. A. Mutirangura, W. Pornthanakasem, A. Theamboonlers, V. Sriuranpong, P. Lertsanguansinchi, and S. Yenrudi et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma Clin Cancer Res 4 3 1998 665 669
14. Yip TTC, Cho CS, Lau WH, Ngan RKC, Lim KP, Cheng WW, et al. PCR detection of DNA encoding Epstein-Barr virus latent membrane protein-1 in cell free sera of nasopharyngeal carcinoma patients with distant or loco-regional relapses but not in those in complete remission. In: Proceedings of the 89th annual meeting of the american association for cancer research; 1998 March 28-April 1; New Orleans, Louisiana, USA; 1998.
15. T.M. O, G. Yu, K. Hu, and J.C. Li Plasma Epstein-Barr virus immunoglobulin A and DNA for nasopharyngeal carcinoma screening in the United States Otolaryngol Head Neck Surg 136 6 2007 992 997
16. S.F. Leung, B. Zee, B.B. Ma, E.P. Hui, F. Mo, and M. Lai et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma J Clin Oncol 24 34 2006 5414 5418
17. S.F. Leung, A.T. Chan, B. Zee, B. Ma, L.Y. Chan, and P.J. Johnson et al. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type Cancer 98 2 2003 288 291
18. W.I. Wei, A.P. Yuen, R.W. Ng, W.K. Ho, D.L. Kwong, and J.S. Sham Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study Head Neck 26 10 2004 878 883
19. K.C. Chan, E.C. Hung, J.K. Woo, P.K. Chan, S.F. Leung, and F.P. Lai et al. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program Cancer 119 10 2013 1838 1844
20. P. Brousset, V. Butet, S. Chittal, J. Selves, and G. Delsol Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody Lab Invest 67 4 1992 457 464
21. L. Hila, F. Farah, H. Ayari, M. Ferjaoui, W. Dehria, and S. Ben Jilani Epidemiological study, immunohistochemistry and in situ hybridization studies of nasopharyngeal carcinomas: a Tunisian report Pathol Biol (Paris) 57 5 2009 427 429
22. D. Zhang, Y. Mao, L. Xiong, Q. Cao, J. Zhu, and R. Chen Characterization of human Fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications Oncol Lett 5 5 2013 1694 1698
23. N. Heussinger, M. Büttner, G. Ott, E. Brachtel, B.Z. Pilch, and E. Kremmer et al. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma J Pathol 203 2 2004 696 699
24. G.J. Babcock, L.L. Decker, M. Volk, and D.A. Thorley-Lawson EBV persistence in memory B cells in vivo Immunity 9 3 1998 395 404
25. K.C. Chan, J. Zhang, A.T. Chan, K.I. Lei, S.F. Leung, and L.Y. Chan et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients Cancer Res 63 9 2003 2028 2032
26. Y. Liu, Z. Fang, L. Liu, S. Yang, and L. Zhang Detection of Epstein-Barr virus DNA in serum or plasma for nasopharyngeal cancer: a meta-analysis Genet Test Mol Biomarkers 15 7-8 2011 495 502
27. K.C. Chan, S.F. Leung, S.W. Yeung, A.T. Chan, and Y.M. Lo Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients Clin Cancer Res 14 15 2008 4809 4813
28. J.Y. Shao, Y.H. Li, H.Y. Gao, Q.L. Wu, N.J. Cui, and L. Zhang et al. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma Cancer 100 6 2004 1162 1170
29. J.C. Lin, W.Y. Wang, K.Y. Chen, Y.H. Wei, W.M. Liang, and J.S. Jan et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 350 24 2004 Jun 10 2461 2470
30. S.F. Leung, J.S. Tam, A.T. Chan, B. Zee, L.Y. Chan, and D.P. Huang et al. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody Clin Chem 50 2 2004 339 345
31. C.W. Twu, W.Y. Wang, W.M. Liang, J.S. Jan, R.S. Jiang, and J. Chao et al. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 67 1 2007 130 137
32. J.Y. Shao, Y. Zhang, Y.H. Li, H.Y. Gao, H.X. Feng, and Q.L. Wu et al. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma Anticancer Res 24 6 2004 4059 4066
33. S.J. Chai, K.C. Pua, A. Saleh, Y.Y. Yap, P.V. Lim, and S.K. Subramaniam et al. Clinical significance of plasma Epstein-Barr virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinoma J Clin Virol 55 1 2012 34 39
34. K. Shotelersuk, C. Khorprasert, S. Sakdikul, W. Pornthanakasem, N. Voravud, and A. Mutirangura Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer Clin Cancer Res 6 3 2000 1046 1051
35. Y.L. Luo, G.P. Ou, P.D. Chi, Y.N. Liang, Y.H. Liu, and M.Y. Huang Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma Ai Zheng 28 1 2009 76 78
36. W.N. Mo, A.Z. Tang, L. Zhou, G.W. Huang, Z. Wang, and Y. Zeng Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen Chin Med J (Engl) 122 10 2009 1173 1178
37. S. Kondo, T. Horikawa, H. Takeshita, C. Kanegane, Y. Kasahara, and T.S. Sheen et al. Diagnostic value of serum EBV-DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patients Cancer Sci 95 6 2004 508 513
38. J.R. Hsiao, Y.T. Jin, and S.T. Tsai Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma Cancer 94 3 2002 723 729
39. X. Yang, A.M. Goldstein, C.J. Chen, C.S. Rabkin, J.Y. Chen, and Y.J. Cheng et al. Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan Int J Cancer 118 3 2006 780 784
40. H. Fan, J. Nicholls, D. Chua, K.H. Chan, J. Sham, and S. Lee et al. Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus Int J Cancer 112 6 2004 1036 1041
41. S.M. Krishna, S. James, J. Kattoor, and P. Balaram Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin Jpn J Clin Oncol 34 6 2004 307 311
42. K.H. Chan, Y.L. Gu, F. Ng, P.S. Ng, W.H. Seto, and J.S. Sham et al. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma Int J Cancer 105 5 2003 706 709
43. N.M. Baizig, P. Morand, J.M. Seigneurin, H. Boussen, A. Fourati, and S. Gritli et al. Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia Eur Arch Otorhinolaryngol 269 3 2012 1005 1011
44. J.H. Tong, R.K. Tsang, K.W. Lo, J.K. Woo, J. Kwong, and M.W. Chan et al. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma Clin Cancer Res 8 8 2002 2612 2619
45. S.J. Stevens, S.A. Verkuijlen, B. Hariwiyanto, Harijadi, D.K. Paramita, and J. Fachiroh et al. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA Int J Cancer 119 3 2006 608 614
46. M. Adham, A.E. Greijer, S.A. Verkuijlen, H. Juwana, S. Fleig, and L. Rachmadi et al. Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment Clin Cancer Res 19 8 2013 2175 2186
47. Q.T. Le, Q. Zhang, H. Cao, A.J. Cheng, B.A. Pinsky, and R.L. Hong et al. An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma Clin Cancer Res 19 8 2013 2208 2215
48. S. Li, Y. Deng, X. Li, Q.P. Chen, X.C. Liao, and X. Qin Diagnostic value of Epstein-Barr virus capsid antigen-IgA in nasopharyngeal carcinoma: a meta-analysis Chin Med J (Engl) 123 9 2010 1201 1205
49. A.D. Gu, H.Y. Mo, Y.B. Xie, R.J. Peng, J.X. Bei, and J. Peng et al. Evaluation of a multianalyte profiling assay and an enzyme-linked immunosorbent assay for serological examination of Epstein-Barr virus-specific antibody responses in diagnosis of nasopharyngeal carcinoma Clin Vaccine Immunol 15 11 2008 1684 1688
50. D.K. Paramita, J. Fachiroh, S.M. Haryana, and J.M. Middeldorp Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma Clin Vaccine Immunol 16 5 2009 706 711
51. J.W. Tang, E. Rohwäder, I.M. Chu, R.K. Tsang, K. Steinhagen, and A.C. Yeung et al. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma J Clin Virol 40 4 2007 284 288
52. Y.M. Lo, S.F. Leung, L.Y. Chan, K.W. Lo, J. Zhang, and A.T. Chan et al. Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging Ann N Y Acad Sci 906 2000 99 101
53. S.F. Leung, Y.M. Lo, A.T. Chan, K.F. To, E. To, and L.Y. Chan et al. Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA Clin Cancer Res 9 9 2003 3431 3434
54. X. Hou, C. Zhao, Y. Guo, F. Han, L.X. Lu, and S.X. Wu et al. Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy Clin Oncol (R Coll Radiol) 23 2 2011 128 133
55. Y.M. Lo, A.T. Chan, L.Y. Chan, S.F. Leung, C.W. Lam, and D.P. Huang et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA Cancer Res 60 24 2000 6878 6881
56. K.P. Chang, C.L. Hsu, Y.L. Chang, N.M. Tsang, C.K. Chen, and T.J. Lee et al. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma Oral Oncol 44 8 2008 784 792
57. C.K. Sam, A.J. Abu-Samah, and U. Prasad IgA/VCA as a follow-up marker in the monitoring of nasopharyngeal carcinoma Eur J Surg Oncol 20 5 1994 561 564
58. J.C. Niederman, R.W. McCollum, G. Henle, and W. Henle Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies JAMA 203 3 1968 205 209
59. Y.M. Lo, L.Y. Chan, A.T. Chan, S.F. Leung, K.W. Lo, and J. Zhang et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma Cancer Res 59 21 1999 5452 5455
60. J.S. Kalpoe, P.B. Dekker, J.H. van Krieken, R.J. Baatenburg de Jong, and A.C. Kroes Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinomain a low risk area J Clin Pathol 59 5 2006 537 541
61. A.T.C. Chan, B.B. Ma, Y.M. Lo, S.F. Leung, W.H. Kwan, and E.P. Hui et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA J Clin Oncol 22 15 2004 3053 3060
62. 18F-fluoro-2- deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma Cancer 117 19 2011 4452 4459
63. S.M. Cao, H.Q. Min, J.S. Gao, M.H. Hong, X.B. Xiao, and C.Q. Zhang et al. Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma Ai Zheng 22 3 2003 302 306
64. R.L. Hong, C.Y. Lin, L.L. Ting, J.Y. Ko, and M.M. Hsu Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA Cancer 100 7 2004 1429 1437
65. C.L. Hsu, S.C. Chan, K.P. Chang, T.L. Lin, C.Y. Lin, and C.H. Hsieh et al. Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma Oral Oncol 49 6 2013 620 625
66. J.Y. Chan, and S.T. Wong The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma Laryngoscope 2013 [Epub ahead of print]
67. J.C. Lin, W.Y. Wang, W.M. Liang, H.Y. Chou, J.S. Jan, and R.S. Jiang et al. Long-term prognostic effects of plasma Epstein-Barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy Int J Radiat Oncol Biol Phys 68 5 2007 1342 1348
68. F.Y. Liang, W. Sun, P. Han, X. Lu, Y.N. Lian, and X.M. Huang Detecting plasma Epstein-Barr virus DNA to diagnose postradiation nasopharyngeal skull base lesions in nasopharyngeal carcinoma patients: a prospective study Chin J Cancer 31 3 2012 142 149
69. Y. Zhang, H.Y. Gao, H.X. Feng, L. Deng, M.Y. Huang, and B. Hu et al. Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma Zhonghua Yi Xue Za Zhi 84 12 2004 982 986
70. R.K.C. Ngan, W.H. Lau, T.T.C. Yip, W.C. Cho, W.W. Cheng, and C.K. Lim et al. Remarkable application of serum EBV EBER1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy Ann NY Acad Sci 945 2001 73 79
71. K.C. Chan, A.T.C. Chan, S.F. Leung, J.C. Pang, A.Y. Wang, and J.H. Tong et al. Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma Clin Chem 51 11 2005 2192 2195
72. S. Swaminathan, B.S. Huneycutt, C.S. Reiss, and E. Kieff Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes J Virol 66 8 1992 5133 5136
73. J.K.C. Chan, B.Z. Pilch, T.T. Kuo, B.M. Wenig, and A.W.S. Lee Tumours of the nasopharynx L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky, World health organization classification of tumors. Pathology and genetics of head and neck tumours 2005 International Agency of Research in Cancer (IARC) Press Lyon
74. W.T. Ng, C.W. Choi, M.C. Lee, L.Y. Law, T.K. Yau, and A.W. Lee Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong Fam Cancer 9 2 2010 221 228
75. R.K.C. Ngan, T.T.C. Yip, W.W. Cheng, J.K.C. Chan, W.C. Cho, and V.W. Ma et al. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease Clin Cancer Res 8 4 2002 986 994
76. R.K. Ngan, T.T.C. Yip, W.W. Cheng, J.K.C. Chan, W.C. Cho, and V.W. Ma et al. Clinical role of circulating Epstein-Barr virus DNA as a tumor marker in lymphoepithelioma-like carcinoma of the lung Ann N Y Acad Sci 1022 2004 263 270
77. H. Ishii, T. Ogino, C. Berger, N. Köchli-Schmitz, T. Nagato, and M. Takahara et al. Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma J Med Virol 79 5 2007 562 572
78. Z.Y. Wang, Q.F. Liu, H. Wang, J. Jin, W.H. Wang, and S.L. Wang et al. Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy Blood 120 10 2012 2003 2010
79. M. Spacek, P. Hubacek, J. Markova, M. Zajac, Z. Vernerova, and K. Kamaradova et al. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients APMIS 119 1 2011 10 16
80. J. Solassol, K.A. Kreuzer, U. Lass, and C.A. Schmidt Epstein-Barr virus DNA quantitation assessed by a real-time polymerase chain reaction in a case of Burkitt's lymphoma Leuk Lymphoma 41 5-6 2001 669 673
81. M. Leruez-Ville, R. Seng, P. Morand, F. Boufassa, F. Boue, and C. Deveau et al. Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma HIV Med 13 8 2012 479 487
82. A. Rosselet, D.H. Vu, P. Meylan, A.S. Chaubert, M. Schapira, and M. Pascual et al. Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease Clin Transplant 23 1 2009 74 82
83. C. Merlino, R. Cavallo, M. Bergallo, F. Giacchino, C. Bollero, and A. Negro Ponzi et al. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients New Microbiol 26 2 2003 141 149
84. J.K.C. Chan, T.T.C. Yip, W.Y. Tsang, Y.F. Poon, C.S. Wong, and V.W.S. Ma Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumors and tumorlike lesions of the salivary gland Arch Pathol Lab Med 118 10 1994 994 997
85. Y.M. Lo, W.Y. Chan, E.K. Ng, L.Y. Chan, P.B. Lai, and J.S. Tam et al. Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma Clin Cancer Res 7 7 2001 1856 1859